We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Wireless Monitor Checks Vital Signs on Hospital Ward

By HospiMedica International staff writers
Posted on 13 May 2013
An ultrathin adhesive strip continuously monitors the patient’s heart rate, respiratory rate, and temperature, significantly increasing hospital surveillance capabilities. More...


The SensiumVitals vital signs monitoring solution is a disposable ultra-light weight, wireless device that enables the rapid detection of changes in temperature, heart, and respiration rates. Patches containing pre-gelled electrocardiogram (ECG) electrodes are attached to the patient’s chest to provide continuous monitoring of vital signs, which can be viewed on-screen at the hospital ward’s central station, on a portable web-enabled device, or as automatic alerts sent out to the doctors’ and nurses’ pagers or smart phones. The device can also seamlessly deliver patient vital signs data to a hospital’s electronic medical record (EMR) system.

SensiumVitals is targeted at general wards, unlike traditional wired monitoring products, which are usually only found in intensive care units (ICUs). Using the device also provides significant cost-savings, as continuous monitoring can reduce the number of patients who have to be admitted or readmitted to the ICU, since any deterioration can be identified and dealt with immediately. Of the nurses who used the device, 85% reported that continuous monitoring of vitals was useful. The SensiumVitals disposable wireless vital signs monitoring solution is a product of Toumaz (Abingdon, UK), and has been approved by the US Food and Drug Administration (FDA).

“The efficacy of this type of patient monitoring device in clinical practice and its ability to immediately alert medical professionals to patient deterioration has the potential to deliver tangible improvements in patient outcomes, reduce hospital stays, and aid in safeguarding patient health,” said Anthony Sethill, CEO of Toumaz.

Related Links:
Toumaz


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.